1h Free Analyst Time
The sinusitis drugs market is poised to grow by $801.39 million during 2023-2027, accelerating at a CAGR of 6.23% during the forecast period. The market is driven by the rising prevalence of sinusitis, growing awareness among people about sinusitis treatment, and increasing mergers and acquisitions.Speak directly to the analyst to clarify any post sales queries you may have.
This report on the sinusitis drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment.
The sinusitis drugs market is segmented as below:
By Product
- Steroid nasal sprays
- Antibiotics
- Decongestants
- Other drugs
By Disease Type
- Acute sinusitis
- Chronic sinusitis
- Sub-acute sinusitis
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
This report on the sinusitis drugs market covers the following areas:
- Sinusitis drugs market sizing
- Sinusitis drugs market forecast
- Sinusitis drugs market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The analyst's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Disease Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Executive Summary
The analyst recognizes the following companies as the key players in the global sinusitis drugs market: AbbVie Inc., Alembic Pharmaceuticals Ltd., Aurobindo Pharma Ltd., Bayer AG, Bionpharma Inc., CHIESI Farmaceutici SpA, Cipla Ltd., Dr Reddys Laboratories Ltd., Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, Hikma Pharmaceuticals Plc, Johnson and Johnson, Merck and Co. Inc., Neopharma Corp., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teligent Inc., and Teva Pharmaceutical Industries Ltd.Commenting on the report, one of the report's analysts said: 'The latest trend gaining momentum in the market is increasing investments in r and d by major players.'
According to the report, one of the major drivers for this market is the rising prevalence of sinusitis.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Alembic Pharmaceuticals Ltd.
- Aurobindo Pharma Ltd.
- Bayer AG
- Bionpharma Inc.
- CHIESI Farmaceutici SpA
- Cipla Ltd.
- Dr Reddys Laboratories Ltd.
- Fresenius SE and Co. KGaA
- GlaxoSmithKline Plc
- Hikma Pharmaceuticals Plc
- Johnson and Johnson
- Merck and Co. Inc.
- Neopharma Corp.
- Novartis AG
- Pfizer Inc.
- Sanofi SA
- Sun Pharmaceutical Industries Ltd.
- Teligent Inc.
- Teva Pharmaceutical Industries Ltd.
